Axinn is pleased to announce that Chad Landmon has been selected as one of Connecticut Law Tribune’s “New Leaders in the Law” for 2012. Landmon was chosen for the honor, which recognizes 60 attorneys from more than 200 nominations under the age of 40 who have made significant achievements to the Connecticut legal profession to distinguish them from their peers.
Chad Landmon is the co-chair of Axinn’s intellectual property practice group and chair of the firm’s FDA practice. Chad was recognized for his stellar litigation skills and wins for clients surrounding the development and marketing of generic drugs and human tissue products. Recently, Chad led the Axinn team in obtaining a favorable decision for its client, Alvogen, Inc. which allowed Alvogen's valuable generic version of the antibiotic Vancocin® to remain on the market. He was also honored for his contributions to his practice and the IP law community, as he often speaks and writes on key issues of interest, and for his involvement in his community of Southbury, CT where he was recently re-elected to the Board of Selectmen.